Abstract: Lovastatin (LOV) is a drug used to treat hypercholesterolemia. Recent studies have identified its antioxidant effects and potential use in the treatment of some types of cancer. However, the low bioavailability related to its poor water solubility limits its use in solid oral dosage forms. Therefore, to improve the solubility of LOV three eutectic systems of LOV with the carboxylic acids benzoic (BEN), salicylic (SAL) and cinnamic (CIN) were obtained. Both binary phase and Tammann diagrams were constructed using differential scanning calorimetry (DSC) data of mixtures prepared from 0.1 to 1.0 molar ratios. Binary mixtures and eutectics were prepared by liquid-assisted grinding. The eutectics were further characterized by DSC and powder X-ray diffraction (PXRD), Fourier-transform infrared spectroscopy (FT-IR) and scanning electron microscopy (SEM). The LOV-BEN, LOV-SAL and LOV-CIN system formed a eutectic at an LOV mole fraction of 0.19, 0.60 and 0.14, respectively. The systems exhibited improvements in LOV solubility, becoming more soluble by five-fold in the LOV-SAL system and approximately four-fold in the other two systems. Considering that the solubility enhancements and the carboxylic acids used are generally recognized as safe by the U.S. Food and Drug Administration (FDA), the LOV eutectic systems are promising materials to be used in a solubility enhancement strategy for pharmaceutical product formulation.
Introduction
Eutectic mixtures are multicomponent organic materials formed by two or more crystalline solids that are immiscible in the solid state and miscible in the liquid state [1, 2] . Their formation occurs via noncovalent forces [3, 4] , mainly hydrogen bonding, ionic and van der Waals forces, and aromatic interactions [4] . In general, the melting temperature of the eutectic is lower than the melting temperatures of their parent components [5] . These systems can be considered as intimately physically blended, with high thermodynamic functions, such as free energy, enthalpy and entropy [6] , 
Materials and Methods

Materials
The lovastatin (LOV) raw material was purchased from Valdequimica, Brazil (purity reported to be >99%) and used without further purification. Adipic acid (ADI, 99% purity), citric acid (CIT, 99% purity), and tartaric acid (TAR, 99% purity) were acquired from Fischer Scientific (Hampton, NH, USA). Benzoic acid (BEN, 99% purity), salicylic acid (SAL, 99% purity) and cinnamic acid (CIN, 99% purity) were purchased from Merck (Darmstadt, Hesse, Germany), Mallinckrodt (Phillipsburg, NY, USA) and Sigma-Aldrich (Saint Louis, MO, USA), respectively. Lovastatin pharmaceutical secondary standard traceable to USP and PhEur Fluka brand used in the HPLC quantification studies was purchased from Sigma-Aldrich. All solvents were HPLC/UV grade, and water was purified using a Millipore system filtered through a Millipore 0.22 µm Millipak 40 membrane.
Lovastatin Eutectic Mixture Screening
Lovastatin and the carboxylic acids adipic (ADI), citric (CIT) tartaric (TAR), BEN, SAL and CIN were individually and accurately weighed to obtain 50 mg of a binary mixture in a 1:1 molar ratio. The binary mixtures were ground together using liquid (ethanol 20 µL) assisted grinding technique. The obtained solids were evaluated in a DSC to determine the eutectic formation.
LOV-BEN, LOV-SAL and LOV-CIN Eutectic Systems
Determination of Mixture Composition at the Eutectic Point
The composition at the eutectic point of LOV and the selected carboxylic acid (BEN, SAL or CIN) was obtained by the construction of Tammann and binary phase diagrams. The diagrams were prepared according to the literature [11, 39] , considering the recommendations given by Rycerz (2013) for the use of DSC data [39] . Different molar ratios of LOV and the selected carboxylic acids (e.g., 0:1, 0.1:0.9, 0.2:0.8, 0.3:0.7, 0.4:0.6, 0.5:0.5, 0.6:0.4, 0.7:0.3, 0.8:0.2, and 0.9:0.1) were prepared as described in the previous section. Briefly, the appropriate amount of each component to obtain 50 mg of the desired binary mixture was placed in a glass mortar and pestle. The mixture was then ground for 10 minutes, assisted by 20 µL of ethanol. Then, 2 mg of the obtained solid was placed into an aluminum crucible and analyzed from 40 to 200 °C at a heating rate of 10 °C/min using the DSC equipment described below. Higher and lower heating rates (e.g., 5 °C/min and 50 °C/min) were used to improve thermal events and avoid peak overlap. In the phase diagram construction, the onset temperature of 
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Lovastatin Eutectic Mixture Screening
LOV-BEN, LOV-SAL and LOV-CIN Eutectic Systems
Determination of Mixture Composition at the Eutectic Point
The composition at the eutectic point of LOV and the selected carboxylic acid (BEN, SAL or CIN) was obtained by the construction of Tammann and binary phase diagrams. The diagrams were prepared according to the literature [11, 39] , considering the recommendations given by Rycerz (2013) for the use of DSC data [39] . Different molar ratios of LOV and the selected carboxylic acids (e.g., 0:1, 0.1:0.9, 0.2:0.8, 0.3:0.7, 0.4:0.6, 0.5:0.5, 0.6:0.4, 0.7:0.3, 0.8:0.2, and 0.9:0.1) were prepared as described in the previous section. Briefly, the appropriate amount of each component to obtain 50 mg of the desired binary mixture was placed in a glass mortar and pestle. The mixture was then ground for 10 min, assisted by 20 µL of ethanol. Then, 2 mg of the obtained solid was placed into an aluminum crucible and analyzed from 40 to 200 • C at a heating rate of 10 • C/min using the DSC equipment described below. Higher and lower heating rates (e.g., 5 • C/min and 50 • C/min) were used to improve thermal events and avoid peak overlap. In the phase diagram construction, the onset temperature of the first endothermic event was used as the solidus point and the peak of the second endothermic event was considered the liquidus point. In the case of the Tammann diagrams, the onset temperature and the enthalpy of fusion of the first endothermic event were used. The analyses of data were performed using TA Instruments-Waters LLC Universal Analysis 2000 software (version 4.5A, New Castle, DE, USA, 2016). Each analysis was performed in triplicate.
Preparation of Bulk Mixtures at the Eutectic Composition
To perform solid-state characterization and solubility assessments, the LOV-BEN, LOV-SAL and LOV-CIN eutectic systems were prepared in a larger amount in their respective eutectic composition. The same method as described in Section 2.2 was used for the scale-up. In short, the following amounts were accurately weighed: for the LOV-BEN system, 438 mg LOV and 563.7 mg BEN (43.7:56.3 wt%); for the LOV-SAL system, 662 mg LOV and 339.0 mg SAL (66.2:33.8 wt%); and for the LOV-CIN system, 308 LOV and 692.9 CIN (30.8:69.2 wt%). The components of each system were mixed and homogenized for 20 min in a glass mortar and pestle using 400 µL of ethanol as a catalyst. The obtained solids were dried at 60 • C for 1 h and stored in a desiccator until further analysis.
Characterization of the Eutectic Mixtures
Differential Scanning Calorimetry (DSC) Analysis
Differential scanning calorimetry curves of the obtained solids were acquired using a DSC-Q200 (TA Instrument, New Castle, DE, USA) equipped with a TA Refrigerated Cooling System 90, using aluminum crucibles with approximately 2 mg of the sample under a dynamic nitrogen atmosphere (50 mL/min) and a heating rate of 10 • C/min in the temperature range from 40 to 200 • C.
Powder X-ray Diffraction (PXRD) Study
Powder X-ray diffraction patterns were collected using a PANalytical Empyrean diffractometer equipped with a Cu Kα source (λ = 1.5418 Å) operated at 45 kV and 40 mA. Powder samples were placed onto a zero-background sample holder. The patterns were recorded over an angular range of 4-40 • (2θ) with a step size of 0.0130 • and a step time of 48 s using a silicon strip detector (PIXcel 1D). The diffractograms were obtained at ambient conditions.
Fourier Transform Infrared (FT-IR)
Fourier transform infrared spectra were recorded on a Thermo Scientific Nicolet 6700 FT-IR (Waltham, MA, USA) fitted with a diamond attenuated total reflectance (ATR) accessory. The samples were placed into the ATR cell without further preparation and analyzed in the range of 4000-600 cm −1 , collecting 32 scans at a resolution of 4 cm −1 .
Scanning Electron Microscopy (SEM)
Micrographs were obtained using a Hitachi Tabletop TM3000 scanning electron microscope (Fischeln, Krefeld, Germany) operated in the range of 5-30 kV. The samples were mounted on the sample holder using carbon double-sided adhesive tape. Vacuum was reached using an oil-free system consisting of a diaphragm pump for rough evacuation and a high-performance turbo-molecular pump for main pumping. The apparent solubilities of LOV and LOV eutectics were determined using the excess method in sodium lauryl sulphate (SLS) 0.25% (w/v) by oversupplying the solid to 1.5 mL of pre-equilibrated media at 37.5 • C in microtubes. The resulting slurry was maintained at constant temperature and agitation using a BIOSAN TS-100C Thermo-Shaker (Riga, Latvia) for 24 h. After this time, samples were centrifuged at 6000 rpm for 10 min in a Thermo Scientific Sorvall ST 16R centrifuge maintaining the temperature of evaluation. The samples were filtered through a 0.45 µm filter using a Sartorius stainless-steel syringe filter holder. The volume was adjusted accordingly to obtain a concentration within the analytical curve.
Intrinsic Dissolution Rate (IDR) Determination
Intrinsic dissolution rate determination was conducted using rotating disk method according to USP30-NF25 1087 Apparent dissolution test [40] . First, 100 mg of the sample was compacted into 0.8 cm 2 surface using a VIV TEK hydraulic press (Yangzhou, Jiangsu, China) with a manometer to 290 psi. Samples were analyzed in a SOTAX s7 dissolution test system, using 300 mL of SLS 0.25% (w/v) previously heated at 37 ± 0.5 • C as a dissolution medium and at a rotation speed of 75 rpm. Five mL of the samples were withdrawn at specific time intervals. To maintain a constant total volume a 5 mL aliquot of preheated fresh medium was replaced into the vessels. The sample aliquots were filtered using a 0.45 µm membrane placed into a Sartorius stainless-steel syringe filter holder and injected without further dilutions. The sink conditions were maintained throughout the dissolution experiment.
High-Performance Liquid Chromatography (HPLC) Analysis
The drug concentration was determined using the HPLC pharmacopeial method [41] . A Dionex Ultimate 3000 HPLC system (Waltham, MA, USA), equipped with variable wavelength detector, pump, variable temperature compartment column and an autosampler was used. The mobile phase was composed of 65% acetonitrile and 35% water with 0.1% phosphoric acid, a flow rate of 1 mL/min, 50 µL injection volume, detection at 238 nm in a Nucleosil 100-5C18 column (250 mm × 4.0 mm, 5 µm), and a temperature of 37.5 • C were used.
A five-standards calibration curve of LOV concentrations ranging from 5 to 25 µg/mL was injected in the same sequence as the samples. The obtained regression coefficient (R 2 ) was in all cases ≥0.99. Each experiment was performed in triplicate, and average values were calculated.
Results
Eutectic Mixture Screening
Differential scanning calorimetry is the primary technique used to identify eutectic formation; hence, it was applied to screen the LOV and coformers/excipients in 1:1 binary mixture composition. Adipic acid, CIT and TAR were also evaluated and did not form eutectic mixtures with LOV. On the other hand, BEN, SAL and CIN were able to form eutectic mixtures with LOV. As expected for eutectic mixtures, a unique endothermic event is observed in Figure 2a -c corresponding to LOV-BEN, LOV-SAL and LOV-CIN eutectic formation, respectively. The thermograms show a significant reduction in the melting temperature of the eutectic systems compared to the melting temperatures of the pure compounds, confirming eutectic formation. Therefore, the composition at the eutectic point, the solid-state characterization and the solubility analyses were performed on the LOV-BEN, LOV-SAL and LOV-CIN systems. 
Binary Phase and Tammann Diagrams
Suitable determination of eutectic composition requires the construction of both the binary and Tammann diagrams [39] . In the phase diagram, the melting temperature of the eutectic mixture (solidus point) and the excess component (liquidus point) is plotted as a function of the mole fraction of LOV. On the other hand, the Tammann diagram shows the systematic dependence of molar enthalpy associated with the eutectic effect on the mole fraction [39] . These diagrams were constructed for the three eutectic systems, LOV-BEN, LOV-SAL and LOV-CIN. The eutectic phase diagrams were drawn using the melting endotherms of the binary mixtures obtained in 
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Solid-State Characterization of LOV Eutectic Systems
One of the requirements for eutectic mixture formation is that the components forming the mixture should have moieties that can interact to form noncovalent interactions [4] , with a major presence of electrostatic interactions [42] . In the case of LOV and the selected carboxylic acids (Figure  1 ), the main interaction should occur between the carbonyl and hydroxyl groups present in both LOV and the carboxylic acids used. However, according to Cherukuvada and Nangia (2014) a new chemical entity is formed when the adhesive interactions (i.e., attractive forces between different molecules) are higher than the cohesive (i.e., intermolecular forces occurring between the same molecule) [6] . In the absence of structural rules to determine whether the cohesive or adhesive forces will dominate ones over the others, the strategy is one of monitoring a new crystal phase or chemical entity formation through appropriate techniques. In this context, PXRD analyses determine crystal structure modifications and FT-IR is useful to follow changes in vibrational modes due to molecular 
One of the requirements for eutectic mixture formation is that the components forming the mixture should have moieties that can interact to form noncovalent interactions [4] , with a major presence of electrostatic interactions [42] . In the case of LOV and the selected carboxylic acids (Figure 1 ), the main interaction should occur between the carbonyl and hydroxyl groups present in both LOV and the carboxylic acids used. However, according to Cherukuvada and Nangia (2014) a new chemical entity is formed when the adhesive interactions (i.e., attractive forces between different molecules) are higher than the cohesive (i.e., intermolecular forces occurring between the same molecule) [6] . In the absence of structural rules to determine whether the cohesive or adhesive forces will dominate ones over the others, the strategy is one of monitoring a new crystal phase or chemical entity formation through appropriate techniques. In this context, PXRD analyses determine crystal structure modifications and FT-IR is useful to follow changes in vibrational modes due to molecular interactions in the solid state [43] ; because, it is quite sensible to crystal structure modifications, conformational rearrangements and chemical environment changes. Therefore, the purpose of this section is to show that no new chemical entity or crystalline phase has been prepared, only the eutectic systems of LOV-BEN, LOV-SAL and LOV-CIN.
PXRD and FT-IR Analyses
Powder X-ray diffraction and FT-IR analyses were performed to determine crystalline forms as a qualitative indicator of the crystallinity of the samples and interactions presented between LOV and the selected carboxylic acids. The rise of new or shifted bands in the FT-IR spectrum is indicative of molecular interactions in the solid state [14] . In addition, new reflections in the PXRD pattern that could not be assigned to any of the pure components is evidence of modifications in the crystal structure. Figure 6 presents the PXRD patterns and Figure S1 shows the FT-IR spectra of LOV, pure BEN, SAL and CIN and their respective eutectic mixtures, LOV-BEN (a), LOV-SAL (b) and LOV-CIN (c).
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Powder X-ray diffraction and FT-IR analyses were performed to determine crystalline forms as a qualitative indicator of the crystallinity of the samples and interactions presented between LOV and the selected carboxylic acids. The rise of new or shifted bands in the FT-IR spectrum is indicative of molecular interactions in the solid state [14] . In addition, new reflections in the PXRD pattern that could not be assigned to any of the pure components is evidence of modifications in the crystal structure. Figure 6 presents the PXRD patterns and Figure S1 shows the FT-IR spectra of LOV, pure BEN, SAL and CIN and their respective eutectic mixtures, LOV-BEN (a), LOV-SAL (b) and LOV-CIN (c). Although the PXRD patterns of LOV and the selected carboxylic acids possess several superimposed reflections, it is possible to distinguish at least two characteristic reflections. In the case of BEN, the reflections at 23.79 • and 27.76 • are distinctive and relatively intense. In the case of the LOV-BEN eutectic mixture, considering that the mole ratio at the eutectic composition is equivalent to 43.7:56.3 wt% of the parent compounds, the reflection of both components is present in the PXRD pattern as shown in Figure 6a . It is also possible to observe the split peak approximately 8 • corresponding to the near reflections of LOV at 7.94 • and BEN at 8.07 • .
Similarly, SAL presents two distinctive reflections at 28.01 • and 30.69 • . However, the mole ratio of this eutectic system is equivalent to 66.2:33.8 wt%, with a higher content of LOV, and consequently, the PXRD pattern of the LOV-SAL eutectic mixture presented in Figure 6b (Figure 7h ) have significantly different morphologies compared to the individual components. A decrease in particle size related to the intrinsic characteristics of the grinding process is also evident in the three eutectic systems.
Solubility Determinations of the Eutectic Systems
To evaluate the impact of eutectic mixture formation on drug solubility improvements, the apparent solubility was evaluated from two different compositions. The first was the eutectic composition obtained from the phase and Tammann diagrams. The second composition was selected by observation from the thermograms in Figures 3-5 , corresponding to LOV-BEN, LOV-SAL and LOV-CIN, respectively. Therefore, the composition out of the eutectic point was selected from the DSC curves showing a unique endothermic event and a straight baseline. The compositions at the eutectic point were 0. Eutectic materials were evaluated after solubility determinations by PXRD measurements, which are presented in Figure S2 (Supporting Information). The same PXRD pattern was observed from the eutectic before and after solubility evaluations. In the case of LOV-CIN eutectics, the disappearance of a reflection at 5.63 • (2θ position) related to the CIN raw material was observed. Therefore, the PXRD patterns confirmed that no dissociation of components had occurred in the three systems. Furthermore, there was no evidence of a new phase or cocrystal formation from the starting materials or any other crystal structure modification.
It is well known that bioavailability and the therapeutic effect of a drug depends on solubility and dissolution rate [44] . Moreover, IDR value has been demonstrated to be useful to correlate the in vivo drug dissolution dynamics [45] . Hence, the IDR was determined for the LOV-SAL eutectic system which showed to be the best solubility enhancer for LOV. Figure 8 shows a linear behavior in the intrinsic dissolution profile of pure LOV and the LOV-SAL system, with IDR values of (0.0096 ± 0.0004) mg cm −2 min −1 and (0.0284 ± 0.0002) mg cm −2 min −1 , respectively, indicating that the LOV-SAL eutectic mixture showed in fact an important increment of solubility in respect to pure LOV. Although higher increments in LOV solubility were obtained using strategies based on nanotechnologies [27, 31] , it is important to stress that the eutectic formation approach is a reproducible and simple method with less expensive processing which produces an intermediary material during the formulation process. The latter conditions could be highly advantageous for pharmaceutical productions.
Conclusions
Binary eutectic mixtures of LOV with benzoic, salicylic and cinnamic carboxylic acids were able to be produced through liquid assisted grinding. Lovastatin showed improvements in solubility in all three systems. The increment of LOV solubility was found to be five-fold for the lovastatin-salicylic acid system and around four-fold for the other two systems. Further, PXRD analyses showed no dissociation of components from the eutectic system as well as no crystal structure modifications after solubility assessment. Considering the enhancement of LOV solubility, the use of carboxylic acids which are GRAS and EAFUS substances, and the accessibility of the method for the pharmaceutical industry, our results indicate that these lovastatin eutectic systems have promising applications in the preparation of new pharmaceutical formulations. 
